Therapeutic Evaluation of Synthetic Peucedanocoumarin III in an Animal Model of Parkinson’s Disease

The motor and nonmotor symptoms of Parkinson’s disease (PD) correlate with the formation and propagation of aberrant α-synuclein aggregation. This protein accumulation is a pathological hallmark of the disease. Our group recently showed that peucedanocoumarin III (PCIII) possesses the ability to dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Ham, Sangwoo, Kim, Heejeong, Yoon, Jin-Ha, Kim, Hyojung, Song, Bo Reum, Choi, Jeong-Yun, Lee, Yun-Song, Paek, Seung-Mann, Maeng, Han-Joo, Lee, Yunjong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862101/
https://www.ncbi.nlm.nih.gov/pubmed/31689937
http://dx.doi.org/10.3390/ijms20215481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862101/
https://www.ncbi.nlm.nih.gov/pubmed/31689937
http://dx.doi.org/10.3390/ijms20215481

Ejemplares similares